Literature DB >> 20428646

Clinical presentation of leptospirosis: a retrospective study of 201 patients in a metropolitan city of Brazil.

Elizabeth F Daher1, Rafael Sa Lima, Geraldo B Silva Júnior, Eveline C Silva, Nahme Nn Karbage, Raquel S Kataoka, Paulo C Carvalho Júnior, Max M Magalhães, Rosa Ms Mota, Alexandre B Libório.   

Abstract

INTRODUCTION: leptospirosis is a zoonosis of worldwide importance. The disease is endemic in Brazil. This study was conducted to describe the clinical and laboratory presentation of leptospirosis in a metropolitan city of Brazil.
METHODS: this is a retrospective study including 201 consecutive patients with leptospirosis admitted to tertiary hospitals in Fortaleza, Brazil, between 1985 and 2006. All patients had clinical and epidemiological data suggestive of leptospirosis, and positive laboratorial test for leptospirosis (microscopic agglutination test, MAT, higher than 1:800).
RESULTS: a total of 201 patients were included, with mean age of 38.9 + or - 15.7 years; 79.1% were male. The mean length from onset of symptoms to admission was 7 + or - 3 days. The main clinical signs and symptoms at admission were fever (96.5%), jaundice (94.5%), myalgia (92.5%), headache (74.6%), vomiting (71.6%) and dehydration (63.5%). Hemorrhagic manifestations were present in 35.8%. Acute kidney injury was found in 87% of the patients. Platelet count was less than 100,000/mm(3) in 74.3%. Hematuria was found in 42.9%. Death occurred in 31 cases (15.4%).
CONCLUSIONS: leptospirosis is a globally relevant disease with potential fatal outcome. Signs and symptoms suggestive of leptospirosis must be known by any physician in order to institute early adequate treatment to improve outcome. Early indication and daily hemodialysis seems to be beneficial in this group of patients.

Entities:  

Mesh:

Year:  2010        PMID: 20428646

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  21 in total

1.  Leptospirosis in the elderly: the role of age as a predictor of poor outcomes in hospitalized patients.

Authors:  Elizabeth De Francesco Daher; Douglas de Sousa Soares; Gabriela Studart Galdino; Ênio Simas Macedo; Pedro Eduardo Andrade de Carvalho Gomes; Roberto da Justa Pires Neto; Geraldo Bezerra da Silva Junior
Journal:  Pathog Glob Health       Date:  2019-05-26       Impact factor: 2.894

2.  Serial Changes in Complete Blood Counts in Patients with Leptospirosis: Our Experience.

Authors:  Deepa Sowkur Anandarama Adiga; Salony Mittal; Harini Venugopal; Sowmya Mittal
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Pulmonary haemorrhage as the earliest sign of severe leptospirosis in hamster model challenged with Leptospira interrogans strain HP358.

Authors:  Noraini Philip; Sivan Padma Priya; Ahmad Hussein Jumah Badawi; Mohd Hafidz Mohd Izhar; Norhafizah Mohtarrudin; Tengku Azmi Tengku Ibrahim; Zamberi Sekawi; Vasantha Kumari Neela
Journal:  PLoS Negl Trop Dis       Date:  2022-05-18

4.  Epidemiology, clinical and laboratory features of 24 consecutive cases of leptospirosis at a German infectious disease center.

Authors:  Thomas Theo Brehm; Julian Schulze Zur Wiesch; Marc Lütgehetmann; Dennis Tappe; Philip Eisermann; Ansgar W Lohse; Marylyn M Addo; Stefan Schmiedel
Journal:  Infection       Date:  2018-07-17       Impact factor: 3.553

5.  Leptospirosis in Hawaii, USA, 1999-2008.

Authors:  Alan R Katz; Arlene E Buchholz; Kialani Hinson; Sarah Y Park; Paul V Effler
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

6.  Host biomarkers distinguish dengue from leptospirosis in Colombia: a case-control study.

Authors:  Andrea L Conroy; Margarita Gélvez; Michael Hawkes; Nimerta Rajwans; W Conrad Liles; Luis Angel Villar-Centeno; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2014-01-20       Impact factor: 3.090

7.  A disconnect between the neurospirochetoses in humans and rodent models of disease.

Authors:  Juan C Garcia-Monco; Jorge L Benach
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823

8.  Factors associated with thrombocytopenia in severe leptospirosis (Weil's disease).

Authors:  Elizabeth F Daher; Geraldo B Silva; Charles O Silveira; Felipe S Falcão; Marília P Alves; Jório A A A Mota; Joyce B Lima; Rosa M S Mota; Ana Patrícia F Vieira; Roberto da Justa Pires; Alexandre B Libório
Journal:  Clinics (Sao Paulo)       Date:  2014-02       Impact factor: 2.365

9.  Changes in full blood count parameters in leptospirosis: a prospective study.

Authors:  Nipun Lakshitha De Silva; Mjr Niloofa; Narmada Fernando; Lilani Karunanayake; Chaturaka Rodrigo; H Janaka De Silva; Sunil Premawansa; Shiroma M Handunnetti; Senaka Rajapakse
Journal:  Int Arch Med       Date:  2014-06-21

10.  Leptospirosis-associated hospitalizations, United States, 1998-2009.

Authors:  Rita M Traxler; Laura S Callinan; Robert C Holman; Claudia Steiner; Marta A Guerra
Journal:  Emerg Infect Dis       Date:  2014-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.